No Data
No Data
Imperative Care Completes Initial Closing of Series E Financing for up to $150 Million; Shacey Petrovic Appointed to Vice Chair, Board of Directors
Piper Sandler Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $80
Exact Sciences (EXAS) Receives a Buy From Piper Sandler
Express News | Exact Sciences Corp : Bernstein Raises Target Price to $83 From $81
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
Exact Sciences Is Maintained at Buy by Goldman Sachs
No Data
Baboompiak : yup holding onto 100 shares at 57.5